FRONTIER INVESTMENT MGMT CO - RegeneRx Biopharmaceuticals ownership

RegeneRx Biopharmaceuticals's ticker is RGRX and the CUSIP is 75886X108. A total of 4 filers reported holding RegeneRx Biopharmaceuticals in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
FRONTIER INVESTMENT MGMT CO ownership history of RegeneRx Biopharmaceuticals
ValueSharesWeighting
Q4 2018$16,000100,0400.00%
Other shareholders
RegeneRx Biopharmaceuticals shareholders Q1 2019
NameSharesValueWeighting ↓
DUMONT & BLAKE INVESTMENT ADVISORS LLC 22,300$7,0000.00%
Williams Jones Wealth Management, LLC. 200,000$63,0000.00%
View complete list of RegeneRx Biopharmaceuticals shareholders